Experience

• 

  Institute for biological research “siniša stanković”

  Sept 2004 - Sept 2007

  Research assistant

  Behavioral and biochemical effects of various food-restriction regimens in the rats (Marinkovic et al., Physiology and Behavior 2007., Pesic et al., Physiology and Behavior 2010).

• 

  Technische universität münchen

  Oct 2007 - Nov 2012

  At this position I was working in the research team on the ongoing projects in laboratory.• Characterization and further development of a new optical approach to measure fast redox signals with single-organelle resolution in living mice that express genetically-encoded redox biosensors in their neuronal mitochondria (Breckwoldt et al., Nature Medicine 2014).• To study microtubules in intact mammalian neurites, we devised a new imaging assay based on transgenic mice expressing yellow fluorescent protein (YFP) tagged end-binding protein 3 (EB3). This approach allows measuring microtubule dynamics in vivo and in mature neurites in the PNS and CNS under physiological conditions and after exposure to microtubule-modifying drugs (Kleele et al., Nature Communications 2014). Show less In my PhD research I used in vivo microscopy to better understand axonal transport deficits which are widely assumed to be key pathogenic event in ALS and other neurodegenerative diseases. Contrary to expectations, I discovered a dissociation of axonal degeneration and transport deficits in SOD-based ALS models (Marinkovic et al., PNAS 2012). 1. Used wide-filed, confocal and two-photon microscopy to follow transport of fluorescently labelled mitochondria and endosomes in mouse models of ALS.2. Developed experimental technique to follow transport of individual mitochondria using novel mouse transgenic line Thy1-MitoKaede. This approach allows studying of transport characteristics and following destiny of single mitochondria over long distances in axons.3. Manuscript preparation, submission and revision to the peer-reviewed journal and presentation of research at seminars and international conferences. Show less

  • Post-doctoral fellow

    Apr 2012 - Nov 2012

  • PhD student, Misgeld lab and TUM Graduate School "Medical Life Science and Technology"

    Oct 2007 - Mar 2012
• 

  Dzne - german center for neurodegenerative diseases

  Dec 2012 - Dec 2016

  Alzheimer's disease is characterised by cognitive decline driven by malfunctioning and degeneration of neurons. To better understand these changes, I developed an approach which combines two-photon calcium imaging through cranial window with imaging in mouse models of Alzheimer’s disease. Using this technique I am now able to follow same neuronal populations over prolonged periods of time and identify when during the disease course first impairments in neuronal activity occur. The results of the study are published in Brain Journal. Show less

  • Project leader Research Collaboration LMU-SANOFI

    Nov 2014 - Dec 2016

  • Post-doctoral fellow

    Dec 2012 - Oct 2014
• 

  Nanocapture - innovative cancer therapy

  Jan 2017 - Mar 2021

  Project leader and co-founder

  1. Developed the project from early proof-of-principle studies to the fully funded GO-Bio translational project.2. Successful raising of non-dilutive pre-seed funding (total of 5M €) 3. Recruitment and management of team of 6 people4. Responsible for overall strategy as well as for scientific and business development

• 

  Immunic therapeutics

  Apr 2021 - now

  • Senior Manager, Commercial & New Product Planning Lead

    Jan 2024 - now

  • Corporate Development Manager

    Apr 2021 - Dec 2023